Clinical Trial Update: A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and tolerability of combining sirolimus with Hyper-CVAD chemotherapy in adults with lymphoid malignancies, including acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Burkitt Lymphoma
• Lymphoblastic Lymphoma
• Mantle Cell Lymphoma
• T-cell Leukemia Lymphoma

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Lymphoid Malignancies (New or Relapsed), Acute Lymphoblastic Leukemia | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2014-01-03